IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

Objective: to investigate the impact of antirheumatic therapy carried out according to the treat-to-target (T2T) principle on the time course of changes in NT-proBNP levels in patients with early rheumatoid arthritis (RA) over an 18- month follow-up period.Subjects and methods. The investigation enr...

Full description

Bibliographic Details
Main Authors:	I. G. Kirillova, D. S. Novikova, T. V. Popkova, E. V. Udachkina, E. I. Markelova, A. A. Novikov, Yu. N. Gorbunova, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2018-07-01
Series:	Научно-практическая ревматология
Subjects:	early rheumatoid arthritis remarca nt-probnp cardiovascular risk
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2567

Similar Items

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

TIME COURSE OF CHANGES IN BLOOD LIPID PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING TREAT-TO-TARGET ANTIRHEUMATIC THERAPY: ACCORDING TO 18-MONTH FOLLOW-UP FINDINGS
by: E. V. Udachkina, et al.
Published: (2016-07-01)

Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy
by: I G Kirillova, et al.
Published: (2015-05-01)

The course of chronic heart failure in patients with early rheumatoid arthritis on the anti-rheumatic therapy
by: I. G. Kirillova, et al.
Published: (2019-11-01)

CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01)

Subclinical left ventricular dysfunction and N-terminal pro-brain natriuretic peptide in patients with rheumatoid arthritis
by: I. G. Kirillova, et al.
Published: (2022-11-01)

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

The clinical value of determination of natriuretic peptides in acute coronary syndrome
by: Ekaterina Viktorovna Shreyder, et al.
Published: (2010-09-01)

The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA)
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-04-01)

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2019-11-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with coronary heart diseas
by: S V Shalaev, et al.
Published: (2009-05-01)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
by: Weiss NS, et al.
Published: (2021-04-01)

BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF THE HEART DAMAGE IN METABOLIC SYNDROME
by: R. A. Libis, et al.
Published: (2015-04-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
by: E M Mezhonov, et al.
Published: (2012-09-01)

Relationship between N-terminal pro-B-type natriuretic peptide and renal function: the effects on predicting early outcome after off-pump coronary artery bypass surgery
by: Youn Yi Jo, et al.
Published: (2011-07-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS
by: D. G. Shakhin, et al.
Published: (2017-12-01)

N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
by: Gottsauner-Wolf Michael, et al.
Published: (2011-04-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes
by: C. Mady, et al.
Published: (2008-08-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults
by: Ulrike Braisch, et al.
Published: (2022-06-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

N-TerminalPro-B-TypeNatriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction
by: Makbule Ulusoy, et al.
Published: (2013-09-01)

Diagnostic value of N-terminal pro-B-type natriuretic peptide in hemodialysis patients
by: D. S. Sedov, et al.
Published: (2020-02-01)

Association of N-Terminal Pro Brain Natriuretic Peptide with Ventricular Ectopy
by: Shazadi Ambreen , Humaira Fayyaz , Azmat Hayyat
Published: (2021-12-01)

Elevated N‐terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri‐urban township
by: Tess E. Peterson, et al.
Published: (2020-10-01)

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01)

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
by: Nagib Dahdah, et al.
Published: (2013-01-01)

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
by: Kara K. Landry, et al.
Published: (2020-07-01)

N-terminal proBrain Natriuretic Peptide as Indicator of Left Ventricle Hypertrophy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography
by: Mohammad Ariful Munir, et al.
Published: (2013-06-01)

PARALLELS BETWEEN THE HEMODYNAMIC PROFILE AND BIOMARKERS ACTIVITY IN DIFFERENT FORMS OF ACUTE HEART FAILURE IN THE EARLY PERIOD AFTER AORTOCORONARY BYPASS
by: D. A. Laletin, et al.
Published: (2017-11-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs
by: D. S. Novikova, et al.
Published: (2020-01-01)